Entinostat in Chinese Postmenopausal Women Patients With Locally Recurrent or Metastatic Breast Cancer
Status:
Completed
Trial end date:
2018-07-18
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and tolerance of entinostat administered
orally as a single agent in a weekly dosing schedule. Additionally, this study will
characterize the pharmacokinetics parameters in Chinese postmenopausal women with advanced
breast cancer. And to define the profile of adverse events, including laboratory parameters
in these subjects